tiprankstipranks
Mesoblast Limited (AU:MSB)
ASX:MSB
Australian Market
MSB
Mesoblast Limited
RESEARCH TOOLSreports
Want to see AU:MSB full AI Analyst Report?

Mesoblast Limited (MSB) Stock News & Sentiment

313 Followers
Mesoblast Ramps Up Ryoncil Sales, Advances Late-Stage Cell Therapy Pipeline
Premium
Company Announcements
Mesoblast Ramps Up Ryoncil Sales, Advances Late-Stage Cell Therapy Pipeline
22d ago
Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push
Premium
Company Announcements
Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push
23d ago
Mesoblast Director Boosts Indirect Stake in Multimillion-Dollar Share Purchase
Premium
Company Announcements
Mesoblast Director Boosts Indirect Stake in Multimillion-Dollar Share Purchase
1M ago
Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution
Premium
Company Announcements
Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution
1M ago
Mesoblast Issues 3.28 Million New Shares on Option Conversions
Premium
Company Announcements
Mesoblast Issues 3.28 Million New Shares on Option Conversions
1M ago
Mesoblast Seeks ASX Quotation for 3.05 Million New Shares
Premium
Company Announcements
Mesoblast Seeks ASX Quotation for 3.05 Million New Shares
1M ago
Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme
1M ago
More AU:MSB News >

MSB News on the Web

Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil
Simply Wall St
Neutral
Mesoblast Director Boosts Indirect Stake in Multimillion-Dollar Share Purchase
TipRanks News
Bullish
Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution
TipRanks News
Neutral
Mesoblast Issues 3.28 Million New Shares on Option Conversions
TipRanks News
Neutral
Mesoblast Seeks ASX Quotation for 3.05 Million New Shares
TipRanks News
Neutral
Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme
TipRanks News
Neutral
Down almost 20% this year, how high could Mesoblast shares go?
The Motley Fool
Neutral
Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline
Simply Wall St
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
AU:MSB
Sector Average
Media Buzz
This Week1 articles
Weekly Average3 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:MSB’s Media Buzz Sentiment?
1 articles about AU:MSB were published this week. In an average week, 3 articles are published.
    What is AU:MSB’s weekly average amount of articles?
    In an average week, 3 articles about AU:MSB are published.
      What is AU:MSB’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      IMVTImmunovant
      PROKProKidney
      Showing the stocks with the most bullish news sentiment over the past week